Epidemiologic Studies of Familial Breast Cancer

Key points
- The first attempts to determine the influence of family history on breast cancer risk were published in the first half of the twentieth century.
- DeMichele: Departments of Medicine and Epidemiology, The University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania B.
- Preliminary data from the population-based Carolina Breast Cancer Study have been released recently.
- Anderson was among the first to suggest that breast cancer was not a homogeneous disease and that the occurrence of breast cancer was not influenced by genetic factors in a uniform manner.
The first attempts to determine the influence of family history on breast cancer risk were published in the first half of the twentieth century. Although many of these studies have methodological flaws, they consistently demonstrated a twofold to threefold increase in breast cancer risk in mothers and sisters of breast cancer patients. The largest population-based study to estimate breast cancer risk associated with a family history was a study conducted in Sweden that involved 2,660 women. Within this study cohort, women with an affected relative had a relative breast cancer risk of 1.7. Relative risks of a similar magnitude were found in a Canadian population-based study and in the U.S. Nurses' Health Study.
Preliminary data from the population-based Carolina Breast Cancer Study have been released recently. Although information on controls has not yet been published, in this series, 20% of individuals with breast cancer reported a first-degree relative with breast cancer, and 49% reported breast cancer in at least one relative of any type. Although information on controls is needed before relative risks of family history in this cohort can be calculated, the familial component to breast cancer is likely to be even greater than has been appreciated in the past.
These data also suggest that increased breast cancer incidence in this population compared with that in the previously cited historical studies, as well as increases in both public awareness and the likelihood that women will discuss a diagnosis of breast cancer with family members, has contributed to higher reporting of affected family members.
Anderson was among the first to suggest that breast cancer was not a homogeneous disease and that the occurrence of breast cancer was not influenced by genetic factors in a uniform manner. In such a setting, a small subset of families with a very high risk of developing breast cancer as the result of a single genetic defect might be obscured in studies in which the majority of breast cancer cases were multifactorial in origin.
To emphasize the hereditary component, Anderson therefore assembled a database enriched for kindreds with a family history of breast cancer. The primary factors that increased risk within families were premenopausal status at time of diagnosis and bilateral disease.
By 1980, a significant body of evidence had accumulated to support the presence of inherited factors responsible for familial clustering of breast cancer, and efforts shifted to determining the inheritance pattern of breast cancer within these families. In 1984, Williams and Anderson examined 200 Danish pedigrees and provided the first evidence for an autosomal dominant breast cancer susceptibility gene with an age-related penetrance, as was supported in 1988 by Newman et al.
Angela DeMichele and Barbara L. Weber
A. DeMichele: Departments of Medicine and Epidemiology, The University of Pennsylvania Cancer Center, Philadelphia, Pennsylvania
Written and revised by
Andrey Nailor, M.D.
Our doctors write and review articles for accuracy and keep them up to date.
health.am provides general information, not medical advice. Always consult a qualified health professional about your own health.
Explore health topics
More in this topic
Cancer →
GuideNew method for better treatment of breast cancer
A new study shows that a novel imaging-based method for defining appropriateness of breast cancer treatment is as accurate as the current standard-of-care and could reduce the need for invasive tissue sampling. The…
31 December 2015
NewsT cells that recognize HER2 teceptor may prevent HER2+ breast cancer recurrence
Recurrence of HER2-positive breast cancer after treatment may be due to a specific and possibly cancer-induced weakness in the patient's immune system - a weakness that in principle could be corrected with a…
31 December 2015
NewsNew breast cancer drug may be effective against other types of cancer
Palbociclib, a new oral drug whose efficacy in combating breast cancer has been demonstrated alone and in combination with endocrine therapy, also has potential to combat other types of cancer, according to a literature…
30 December 2015




